SAN CARLOS, Calif.--(BUSINESS WIRE)--Nov. 4, 2004--Conceptus, Inc. (NASDAQ:CPTS) announced today that the Centers for Medicare and Medicaid Services (CMS) has released the Final Rule for the 2005 ...

Most women who are in their reproductive years use some form of contraception when they wish to avoid pregnancy; calendar, barrier, hormonal, intrauterine, surgical, and male contraceptive options are ...

Five months after convening an advisory committee meeting to discuss concerns about the safety of Essure, the only non-surgical permanent contraceptive, the Food and Drug Administration on Monday ...

When Amanda Dykeman was certain she was done with having children, she had two options for permanent birth control: surgical sterilization, which typically involves general anesthesia and a ...

(HealthDay)—Essure implants used in female sterilization have come under fire in recent years, with women reporting a wide array of problems to the U.S. Food and Drug Administration. A new study from ...

SAN CARLOS, Calif.--(BUSINESS WIRE)--July 27, 2004--Conceptus, Inc. (Nasdaq:CPTS) today provided an update on recent progress in obtaining positive third party payer coverage decisions for Essure(R).

Women implanted with Bayer AG's Essure permanent contraception device were more than 10 times more likely to require post-procedure surgery than those who underwent laparoscopic sterilization, a study ...

FDA withdraws warning letter after resolution In a new draft guidance, the Food and Drug Administration (FDA) announced that they have ordered Bayer to conduct follow-up studies for their permanent ...

A new study appears to confirm what some women have said about a permanent birth control device called Essure. Subscribe to read this story ad-free Get unlimited access to ad-free articles and ...

Hysteroscopic sterilization tied to higher risk of some complications, but not increased medical risks "This study provides a degree of reassurance -- but not certainty," one expert says A new study, ...